Ir para o conteúdo principal

Grafa News and Videos — Page 787

Destaques de Grafa

Grafa

European regulators accept Teva and Medincell’s application for long-acting Schizophrenia injection

Teva Pharmaceutical Industries (NYSE:TEVA) and Medincell announced Thursday that the European Medicines Agency has accepted their Marketing Authorization Application for TEV-749, an investigational long-acting injectable formulation designed to treat adults living with schizophrenia.

Leia mais

GARANTA JÁ SEU GRAFA EDGE

Sign up free to unlock this feature

Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas